Key result
Genetic studies confirmed significant differences in the genetic background between benign and malignant acanthosis nigricans, supporting their classification as separate diseases.
Observational
Genetic evidence supports the clinical distinction between benign and malignant forms of acanthosis nigricans as separate disease entities.
Supports refined diagnostic criteria; leaves open whether genetic testing improves outcomes in acanthosis nigricans.
In a previous paper by one of us (H. O. C.1) the separate character of benign and malignant acanthosis nigricans was stressed. Differences between the two types exist with regard to the age of the patient at the onset of the dermatosis, the course, and the activator of the disorder. It was also pointed out that there may be in the genetic background of the two types significant differences which could furnish additional evidence for the assumption that benign and malignant acanthosis nigricans are separate diseases. The result of our genetic studies has confirmed our early impression. Since some controversy over the necessity of recognizing different types of acanthosis nigricans has arisen, we shall briefly define benign and malignant acanthosis nigricans before reporting our genetic data on these forms of the dermatosis. Pseudo acanthosis nigricans, a third variety, will also be described, and the reasons
No takes yet. Share an insight, caveat, or question.
Helen Ollendorff Curth (1959) conducted an observational in Acanthosis Nigricans. Genetic background was evaluated. Genetic studies confirmed significant differences in the genetic background between benign and malignant acanthosis nigricans, supporting their classification as separate diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: